[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

2019 Wet (Neovascular/Exudative) Macular Degeneration Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... clinical trial research report- “2019 Wet (Neovascular / Exudative) Macular Degeneration Ongoing Clinical Trials Study” analyzes the current scenario of all active Wet (Neovascular / Exudative) Macular Degeneration trials across the world ...

February 2019 146 pages

2019 Wheezing Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Wheezing Ongoing Clinical Trials Study” analyzes the current scenario of all active Wheezing trials across the world. The report presents top level analysis ...

February 2019 52 pages

2019 Whooping Cough Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Whooping Cough Ongoing Clinical Trials Study” analyzes the current scenario of all active Whooping Cough trials ... researched for administering Whooping Cough patients are identified The report includes panorama of ongoing Whooping Cough clinical trials across ...

February 2019 82 pages

2019 Wilms' Tumor Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Wilms' Tumor Ongoing Clinical Trials Study” analyzes the current scenario of all active Wilms' Tumor trials across ... researched for administering Wilms' Tumor patients are identified The report includes panorama of ongoing Wilms' Tumor clinical trials across the ...

February 2019 61 pages

2019 Wiskott-Aldrich Syndrome Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Wiskott-Aldrich Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Wiskott-Aldrich Syndrome trials across the world. The report presents ...

February 2019 54 pages

2019 Women Infertility Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Women Infertility Ongoing Clinical Trials Study” analyzes the current scenario of all active Women Infertility trials across the world. The report presents ...

February 2019 399 pages

2019 Wounds Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Wounds Ongoing Clinical Trials Study” analyzes the current scenario of all active Wounds trials across the world. The report presents top level analysis ...

February 2019 154 pages

2019 Wrinkles Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Wrinkles Ongoing Clinical Trials Study” analyzes the current scenario of all active Wrinkles trials across the world. The report presents top level analysis ...

February 2019 55 pages

2019 Xerosis (Dry Skin) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Xerosis (Dry Skin) Ongoing Clinical Trials Study” analyzes the current scenario of all active Xerosis (Dry Skin) trials across the world. The report ...

February 2019 38 pages

2019 Xerostomia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Xerostomia Ongoing Clinical Trials Study” analyzes the current scenario of all active Xerostomia trials across the world. The report presents top level analysis ...

February 2019 46 pages

2019 X-Linked Agammaglobulinemia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 X-Linked Agammaglobulinemia Ongoing Clinical Trials Study” analyzes the current scenario of all active X-Linked Agammaglobulinemia trials across the world. The report presents ...

February 2019 39 pages

2019 Yellow Fever Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

The ongoing clinical trial research report- “2019 Yellow Fever Ongoing Clinical Trials Study” analyzes the current scenario of all active Yellow Fever trials across ... researched for administering Yellow Fever patients are identified The report includes panorama of ongoing Yellow Fever clinical trials across the ...

February 2019 46 pages

2019 Zika Virus Infections Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Zika Virus Infections Ongoing Clinical Trials Study” analyzes the current scenario of all active Zika Virus Infections trials across the world. The report ...

February 2019 50 pages

2019 Zollinger-Ellison Syndrome (Gastrinoma) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

US$ 2,199.00

... trial research report- “2019 Zollinger-Ellison Syndrome (Gastrinoma) Ongoing Clinical Trials Study” analyzes the current scenario of all active Zollinger-Ellison Syndrome (Gastrinoma) trials across the world. The report ...

February 2019 51 pages

2019 Future of Alcohol Addiction R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... from advancing their products into Phase 3 or Phase 4. Alcohol Addiction Report Description- The 2019 pipeline study on Alcohol Addiction pipeline is a comprehensive research on the drug candidates ...

February 2019 120 pages

2019 Future of Anesthetic Effect R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... from advancing their products into Phase 3 or Phase 4. Anesthetic Effect Report Description- The 2019 pipeline study on Anesthetic Effect pipeline is a comprehensive research on the drug candidates ...

February 2019 75 pages

2019 Future of Attention Deficit Hyperactivity Disorder (ADHD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Attention Deficit Hyperactivity Disorder (ADHD) Report Description- The 2019 pipeline study on Attention Deficit Hyperactivity Disorder (ADHD) pipeline is a comprehensive ...

February 2019 140 pages

2019 Future of Autism R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Autism Report Description- The 2019 pipeline study on Autism pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Autism product pipeline are provided. Company overview, snapshot and ...

February 2019 130 pages

2019 Future of Batten Disease R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Batten Disease Report Description- The 2019 pipeline study on Batten Disease pipeline is a comprehensive research on the ... and actionable insights. Scope of Batten Disease pipeline report includes- An overview of Batten Disease disease including symptoms, causes, diagnosis and ...

February 2019 50 pages

2019 Future of Binge Eating Disorder R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Binge Eating Disorder Report Description- The 2019 pipeline study on Binge Eating Disorder pipeline is a comprehensive research ... count of Binge Eating Disorder pipeline Company wise list of Binge Eating Disorder pipeline Mechanism of Action wise Binge Eating Disorder pipeline ...

February 2019 50 pages

2019 Future of Bladder Pain Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Bladder Pain Syndrome Report Description- The 2019 pipeline study on Bladder Pain Syndrome pipeline is a comprehensive research ... count of Bladder Pain Syndrome pipeline Company wise list of Bladder Pain Syndrome pipeline Mechanism of Action wise Bladder Pain Syndrome pipeline ...

February 2019 50 pages

2019 Future of Brain Ischemia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Brain Ischemia Report Description- The 2019 pipeline study on Brain Ischemia pipeline is a comprehensive research on the ... wise count of Brain Ischemia pipeline Company wise list of Brain Ischemia pipeline Mechanism of Action wise Brain Ischemia pipeline For each pipeline ...

February 2019 42 pages

2019 Future of Canavan Disease R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Canavan Disease Report Description- The 2019 pipeline study on Canavan Disease pipeline is a comprehensive research on the ... and actionable insights. Scope of Canavan Disease pipeline report includes- An overview of Canavan Disease disease including symptoms, causes, diagnosis ...

February 2019 25 pages

2019 Future of Cancer related Pain R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Cancer related Pain Report Description- The 2019 pipeline study on Cancer related Pain pipeline is a comprehensive research on ... wise count of Cancer related Pain pipeline Company wise list of Cancer related Pain pipeline Mechanism of Action wise Cancer related Pain pipeline ...

February 2019 110 pages

2019 Future of Cerebral Palsy (CP) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... from advancing their products into Phase 3 or Phase 4. Cerebral Palsy (CP) Report Description- The 2019 pipeline study on Cerebral Palsy (CP) pipeline is a comprehensive research on the drug candidates ...

February 2019 40 pages

2019 Future of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Report Description- The 2019 pipeline study on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline is a comprehensive ...

February 2019 45 pages

2019 Future of Chronic Traumatic Encephalopathy (CTE) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Chronic Traumatic Encephalopathy (CTE) Report Description- The 2019 pipeline study on Chronic Traumatic Encephalopathy (CTE) pipeline is a comprehensive research ...

February 2019 40 pages

2019 Future of Cluster Headache Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Cluster Headache Syndrome Report Description- The 2019 pipeline study on Cluster Headache Syndrome pipeline is a comprehensive research on the drug ...

February 2019 40 pages

2019 Future of Cognitive Impairment Associated With Schizophrenia (CIAS) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Cognitive Impairment Associated With Schizophrenia (CIAS) Report Description- The 2019 pipeline study on Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline ...

February 2019 80 pages

2019 Future of Complex Regional Pain Syndrome (CPRS) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Complex Regional Pain Syndrome (CPRS) Report Description- The 2019 pipeline study on Complex Regional Pain Syndrome (CPRS) pipeline is a comprehensive ...

February 2019 40 pages

2019 Future of Dental Pain R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Dental Pain Report Description- The 2019 pipeline study on Dental Pain pipeline is a comprehensive research on the drug ... Phase wise count of Dental Pain pipeline Company wise list of Dental Pain pipeline Mechanism of Action wise Dental Pain pipeline For each pipeline ...

February 2019 35 pages

2019 Future of Devic’s Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Devic’s Syndrome Report Description- The 2019 pipeline study on Devic’s Syndrome pipeline is a comprehensive research on the ... wise count of Devic’s Syndrome pipeline Company wise list of Devic’s Syndrome pipeline Mechanism of Action wise Devic’s Syndrome pipeline For each ...

February 2019 80 pages

2019 Future of Drug Addiction R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Drug Addiction pipeline companies from advancing their products into Phase 3 or Phase 4. Drug Addiction Report Description- The 2019 pipeline study on Drug Addiction pipeline is a comprehensive research on the drug ...

February 2019 150 pages

2019 Future of Dyskinesia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Dyskinesia Report Description- The 2019 pipeline study on Dyskinesia pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Dyskinesia product pipeline are provided. Company overview, snapshot and ...

February 2019 130 pages

2019 Future of Encephalitis R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Encephalitis Report Description- The 2019 pipeline study on Encephalitis pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Encephalitis product pipeline are provided. Company overview, snapshot and ...

February 2019 40 pages

2019 Future of Encephalomyelitis R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Encephalomyelitis Report Description- The 2019 pipeline study on Encephalomyelitis pipeline is a comprehensive research on the ... and actionable insights. Scope of Encephalomyelitis pipeline report includes- An overview of Encephalomyelitis disease including symptoms, causes, ...

February 2019 45 pages

2019 Future of Encephalopathy R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Encephalopathy Report Description- The 2019 pipeline study on Encephalopathy pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Encephalopathy product pipeline are provided. Company overview, snapshot and ...

February 2019 60 pages

2019 Future of Fatigue R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Fatigue Report Description- The 2019 pipeline study on Fatigue pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Fatigue product pipeline are provided. Company overview, snapshot and ...

February 2019 40 pages

2019 Future of Fibromyalgia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Fibromyalgia Report Description- The 2019 pipeline study on Fibromyalgia pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Fibromyalgia product pipeline are provided. Company overview, snapshot and ...

February 2019 60 pages

2019 Future of Friedreich Ataxia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... from advancing their products into Phase 3 or Phase 4. Friedreich Ataxia Report Description- The 2019 pipeline study on Friedreich Ataxia pipeline is a comprehensive research on the drug candidates ...

February 2019 70 pages

2019 Future of Globoid Cell Leukodystrophy R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Globoid Cell Leukodystrophy Report Description- The 2019 pipeline study on Globoid Cell Leukodystrophy pipeline is a comprehensive research on the drug ...

February 2019 40 pages

2019 Future of Guillain-Barre Syndrome R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... some of the Guillain-Barre Syndrome pipeline companies from advancing their products into Phase 3 or Phase 4. Guillain-Barre Syndrome Report Description- The 2019 pipeline study on Guillain-Barre Syndrome pipeline is a comprehensive ...

February 2019 40 pages

2019 Future of Hepatic Encephalopathy (HE) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... from advancing their products into Phase 3 or Phase 4. Hepatic Encephalopathy (HE) Report Description- The 2019 pipeline study on Hepatic Encephalopathy (HE) pipeline is a comprehensive research on the drug candidates ...

February 2019 45 pages

2019 Future of Hyperalgesia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Hyperalgesia Report Description- The 2019 pipeline study on Hyperalgesia pipeline is a comprehensive research on the drug ... companies, license providers and universities participating in the Hyperalgesia product pipeline are provided. Company overview, snapshot and ...

February 2019 40 pages

2019 Future of Insomnia R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Insomnia Report Description- The 2019 pipeline study on Insomnia pipeline is a comprehensive research on the drug ... originating companies, license providers and universities participating in the Insomnia product pipeline are provided. Company overview, snapshot and ...

February 2019 90 pages

2019 Future of Interstitial Cystitis R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... from advancing their products into Phase 3 or Phase 4. Interstitial Cystitis Report Description- The 2019 pipeline study on Interstitial Cystitis pipeline is a comprehensive research on the drug candidates ...

February 2019 50 pages

2019 Future of Krabbe Disease R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Krabbe Disease Report Description- The 2019 pipeline study on Krabbe Disease pipeline is a comprehensive research on the ... and actionable insights. Scope of Krabbe Disease pipeline report includes- An overview of Krabbe Disease disease including symptoms, causes, diagnosis and ...

February 2019 40 pages

2019 Future of Low Back Pain R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... their products into Phase 3 or Phase 4. Low Back Pain Report Description- The 2019 pipeline study on Low Back Pain pipeline is a comprehensive research on the ... Phase wise count of Low Back Pain pipeline Company wise list of Low Back Pain pipeline Mechanism of Action wise Low Back Pain pipeline For each ...

February 2019 100 pages

2019 Future of Metachromatic Leukodystrophy (MLD) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Metachromatic Leukodystrophy (MLD) Report Description- The 2019 pipeline study on Metachromatic Leukodystrophy (MLD) pipeline is a comprehensive research on the drug ...

February 2019 40 pages

2019 Future of Mild Cognitive Impairment (MCI) R&D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Mild Cognitive Impairment (MCI) Report Description- The 2019 pipeline study on Mild Cognitive Impairment (MCI) pipeline is a comprehensive research ...

February 2019 65 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers